Document is current
Any future updates will be listed below
-
Authors
Gao, Yiru
Wang, Tengyu https://orcid.org/0009-0008-2277-1718
Nan, Nan https://orcid.org/0000-0003-4702-001X
Tian, Feng
Tan, Lingchen
Yan, Huining
Peng, Xueqiang
Zheng, Shaoqin
He, Yan
Zhang, Haijiao
Li, Hui
Fan, Qing
Suo, Chenhao
Zhang, Wanli
Shi, Yafang
Du, Wei
Jiang, Jincong
Li, Hailong https://orcid.org/0000-0003-0292-6774
Zhang, Mingyu
Wu, Jiahui
Zhou, Haiyao
Cheng, Yan
Nian, Yidi
Wang, Xiao
Sun, Xun
Sheng, Ren https://orcid.org/0000-0002-2293-8986
Zheng, Qianqian https://orcid.org/0000-0001-5906-148X
Ding, Chen https://orcid.org/0000-0002-9195-2255
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32270205)
National Natural Science Foundation of China (32200977)
Natural Science Foundation of Liaoning Province (3190025010)
Natural Science Foundation of Liaoning Province (2025-MS-237)
Ministry of Science and Technology of the People's Republic of China (2022YFC2303003)
- License Information
-
More Information
Article History
Received: 20 May 2025
Accepted: 9 December 2025
First Online: 9 January 2026
Competing interests
: C.D., R.S., Y.G. and S.Z. are inventors of a pending patent application (2022109555819) covering the CD12 sequence described in this study. C.D., Y.G. and Q.Z. are inventors of a pending patent application (2025107526567 and 2025107526618) covering the described applications of CD12 in treating inflammatory diseases in this study. The other authors declare no competing interests.
